Fintel reports that on May 28, 2025, B of A Securities downgraded their outlook for Prothena (NasdaqGS:PRTA) from Neutral to ...

Fintel reports that on May 27, 2025, Oppenheimer downgraded their outlook for Prothena (NasdaqGS:PRTA) from Outperform to ...

DLB and PD are both so-called synucleinopathies, diseases that are characterised by mutations in the SNCA gene coding for alpha-synuclein, leading to the production of misfolded, toxic forms of ...

Alpha-synuclein is a protein that gets misfolded and clumps together in the brains of patients with Parkinson's and other diseases collectively known as synucleinopathies. The protein is thought ...

Introduction Cardiovascular autonomic failure and neurogenic orthostatic hypotension (nOH) are common and disabling features of Parkinson’s disease (PD) and multiple system atrophy (MSA). Compared to ...

Movement disorders are a group of neurological syndromes in which the hallmark symptom is paucity of movement, excessive and/or involuntary movement or tremor. Movement disorders can be ...

This article explores the evolving landscape of Parkinson’s disease treatment, from newly licensed symptomatic therapies to emerging disease-modifying approaches targeting α-synuclein. With a focus on ...

cCenter for Translational Neuromedicine, Faculty of Medical and Health Sciences, University of Copenhagen, Copenhagen, Denmark The existence of specialised structures that allow a continuous exchange ...

Diffusion Tensor Image Analysis ALong the Perivascular Space (DTI-ALPS): revisiting the meaning and significance of the method ...